Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Bortezomib). Showing records 1 – 30 of 64 total matches.

[1] [2] [3]

Search Limiters

Last 2 Years | English Only

Languages

Country

▼ Search Limiters


Princeton University

1. Arlow, Tim. Ubiquitination of the DNA Mismatch Repair Protein Msh2 .

Degree: PhD, 2012, Princeton University

 MSH2 is required for DNA mismatch repair recognition in eukaryotes. Deleterious mutations in human MSH2 account for approximately half of the alleles associated with a… (more)

Subjects/Keywords: Bortezomib; DNA Mismatch Repair; Ubiquitination

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arlow, T. (2012). Ubiquitination of the DNA Mismatch Repair Protein Msh2 . (Doctoral Dissertation). Princeton University. Retrieved from http://arks.princeton.edu/ark:/88435/dsp012n49t172r

Chicago Manual of Style (16th Edition):

Arlow, Tim. “Ubiquitination of the DNA Mismatch Repair Protein Msh2 .” 2012. Doctoral Dissertation, Princeton University. Accessed August 14, 2020. http://arks.princeton.edu/ark:/88435/dsp012n49t172r.

MLA Handbook (7th Edition):

Arlow, Tim. “Ubiquitination of the DNA Mismatch Repair Protein Msh2 .” 2012. Web. 14 Aug 2020.

Vancouver:

Arlow T. Ubiquitination of the DNA Mismatch Repair Protein Msh2 . [Internet] [Doctoral dissertation]. Princeton University; 2012. [cited 2020 Aug 14]. Available from: http://arks.princeton.edu/ark:/88435/dsp012n49t172r.

Council of Science Editors:

Arlow T. Ubiquitination of the DNA Mismatch Repair Protein Msh2 . [Doctoral Dissertation]. Princeton University; 2012. Available from: http://arks.princeton.edu/ark:/88435/dsp012n49t172r


Harvard University

2. Sprague, Jared Michael. TRPV1 Sensitization in Primary Sensory Neurons.

Degree: PhD, Biological Sciences in Dental Medicine, 2014, Harvard University

 Pain is a major personal and community burden throughout the world with currently limited treatment options for persistent pain due to unacceptable side effects, dependence… (more)

Subjects/Keywords: Neurosciences; Bortezomib; Optovin; Sensitization; TRPA1; TRPV1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sprague, J. M. (2014). TRPV1 Sensitization in Primary Sensory Neurons. (Doctoral Dissertation). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:12274115

Chicago Manual of Style (16th Edition):

Sprague, Jared Michael. “TRPV1 Sensitization in Primary Sensory Neurons.” 2014. Doctoral Dissertation, Harvard University. Accessed August 14, 2020. http://nrs.harvard.edu/urn-3:HUL.InstRepos:12274115.

MLA Handbook (7th Edition):

Sprague, Jared Michael. “TRPV1 Sensitization in Primary Sensory Neurons.” 2014. Web. 14 Aug 2020.

Vancouver:

Sprague JM. TRPV1 Sensitization in Primary Sensory Neurons. [Internet] [Doctoral dissertation]. Harvard University; 2014. [cited 2020 Aug 14]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12274115.

Council of Science Editors:

Sprague JM. TRPV1 Sensitization in Primary Sensory Neurons. [Doctoral Dissertation]. Harvard University; 2014. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12274115

3. Mizuno, Hiroki; Nakayama, Takayuki; Miyata, Yasuhiko; Saito, Shigeki; Nishiwaki, Satoshi; Nakao, Norihiko; Takeshita, Kyosuke. Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib.

Degree: 博士(医学), 2018, Nagoya University / 名古屋大学

Hodgkin's lymphoma is frequently associated with mast cell infiltration that correlates directly with disease severity, but the mechanisms underlying this relationship remain unclear. Here, we… (more)

Subjects/Keywords: Hodgkin's lymphoma; mast cells; angiogenesis; fibrosis; bortezomib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mizuno, Hiroki; Nakayama, Takayuki; Miyata, Yasuhiko; Saito, Shigeki; Nishiwaki, Satoshi; Nakao, Norihiko; Takeshita, K. (2018). Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib. (Thesis). Nagoya University / 名古屋大学. Retrieved from http://hdl.handle.net/2237/18834

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mizuno, Hiroki; Nakayama, Takayuki; Miyata, Yasuhiko; Saito, Shigeki; Nishiwaki, Satoshi; Nakao, Norihiko; Takeshita, Kyosuke. “Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib.” 2018. Thesis, Nagoya University / 名古屋大学. Accessed August 14, 2020. http://hdl.handle.net/2237/18834.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mizuno, Hiroki; Nakayama, Takayuki; Miyata, Yasuhiko; Saito, Shigeki; Nishiwaki, Satoshi; Nakao, Norihiko; Takeshita, Kyosuke. “Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib.” 2018. Web. 14 Aug 2020.

Vancouver:

Mizuno, Hiroki; Nakayama, Takayuki; Miyata, Yasuhiko; Saito, Shigeki; Nishiwaki, Satoshi; Nakao, Norihiko; Takeshita K. Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib. [Internet] [Thesis]. Nagoya University / 名古屋大学; 2018. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2237/18834.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mizuno, Hiroki; Nakayama, Takayuki; Miyata, Yasuhiko; Saito, Shigeki; Nishiwaki, Satoshi; Nakao, Norihiko; Takeshita K. Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib. [Thesis]. Nagoya University / 名古屋大学; 2018. Available from: http://hdl.handle.net/2237/18834

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universitat Autònoma de Barcelona

4. Bruna Escuer, Jordi. Neuropatia induïda per Bortezomib. Caracterització i factors de risc en un model experimental.

Degree: Departament de Biologia Cel·lular i de Fisiologia, 2012, Universitat Autònoma de Barcelona

 Introduction Peripheral neuropathy (PN) is a dose-limiting adverse event of most chemotherapeutic drugs. The chemotherapy neurotoxic side effect may be permanent with a negative impact… (more)

Subjects/Keywords: Bortezomib; Neuropatia; Citostatics; Ciències Experimentals; 616.8

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bruna Escuer, J. (2012). Neuropatia induïda per Bortezomib. Caracterització i factors de risc en un model experimental. (Thesis). Universitat Autònoma de Barcelona. Retrieved from http://hdl.handle.net/10803/97366

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bruna Escuer, Jordi. “Neuropatia induïda per Bortezomib. Caracterització i factors de risc en un model experimental.” 2012. Thesis, Universitat Autònoma de Barcelona. Accessed August 14, 2020. http://hdl.handle.net/10803/97366.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bruna Escuer, Jordi. “Neuropatia induïda per Bortezomib. Caracterització i factors de risc en un model experimental.” 2012. Web. 14 Aug 2020.

Vancouver:

Bruna Escuer J. Neuropatia induïda per Bortezomib. Caracterització i factors de risc en un model experimental. [Internet] [Thesis]. Universitat Autònoma de Barcelona; 2012. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10803/97366.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bruna Escuer J. Neuropatia induïda per Bortezomib. Caracterització i factors de risc en un model experimental. [Thesis]. Universitat Autònoma de Barcelona; 2012. Available from: http://hdl.handle.net/10803/97366

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

5. Lee, Saem. Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities.

Degree: MS, Medical Sciences, 2014, Boston University

Bortezomib-based induction therapies have shown to increase complete response rates and are used as an upfront therapy for newly diagnosed multiple myeloma patients. The standard… (more)

Subjects/Keywords: Oncology; Bortezomib; Multiple myeloma; Newly diagnosed

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, S. (2014). Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/14373

Chicago Manual of Style (16th Edition):

Lee, Saem. “Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities.” 2014. Masters Thesis, Boston University. Accessed August 14, 2020. http://hdl.handle.net/2144/14373.

MLA Handbook (7th Edition):

Lee, Saem. “Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities.” 2014. Web. 14 Aug 2020.

Vancouver:

Lee S. Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities. [Internet] [Masters thesis]. Boston University; 2014. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2144/14373.

Council of Science Editors:

Lee S. Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities. [Masters Thesis]. Boston University; 2014. Available from: http://hdl.handle.net/2144/14373


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

6. Papadopoulou, Anastasia. Μεταδιαφοροποιητικές και ανοσορρυθμιστικές ιδιότητες των μεσεγχυματικών κυττάρων του μυελού των οστών στην πειραματική αρθρίτιδα.

Degree: 2011, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

 The recently recognized potential of mesenchymal stromal cells (MSCs) to differentiate into a broad spectrum of tissues and to act as immune regulators has emerged… (more)

Subjects/Keywords: Μεσεγχυματικά στρωματικά κύτταρα; Ρευματοειδής αρθρίτιδα; Αναστολέας πρωτεασώματος Bortezomib; Πειραματική αρθρίτιδα; Mesenchymal stromal cells; Rheumatoid arthritis; Proteasome inhibitor Bortezomib; Experimental arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Papadopoulou, A. (2011). Μεταδιαφοροποιητικές και ανοσορρυθμιστικές ιδιότητες των μεσεγχυματικών κυττάρων του μυελού των οστών στην πειραματική αρθρίτιδα. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/33222

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Papadopoulou, Anastasia. “Μεταδιαφοροποιητικές και ανοσορρυθμιστικές ιδιότητες των μεσεγχυματικών κυττάρων του μυελού των οστών στην πειραματική αρθρίτιδα.” 2011. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed August 14, 2020. http://hdl.handle.net/10442/hedi/33222.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Papadopoulou, Anastasia. “Μεταδιαφοροποιητικές και ανοσορρυθμιστικές ιδιότητες των μεσεγχυματικών κυττάρων του μυελού των οστών στην πειραματική αρθρίτιδα.” 2011. Web. 14 Aug 2020.

Vancouver:

Papadopoulou A. Μεταδιαφοροποιητικές και ανοσορρυθμιστικές ιδιότητες των μεσεγχυματικών κυττάρων του μυελού των οστών στην πειραματική αρθρίτιδα. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2011. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10442/hedi/33222.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Papadopoulou A. Μεταδιαφοροποιητικές και ανοσορρυθμιστικές ιδιότητες των μεσεγχυματικών κυττάρων του μυελού των οστών στην πειραματική αρθρίτιδα. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2011. Available from: http://hdl.handle.net/10442/hedi/33222

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

7. Araújo, Karla Patrícia Cardoso. Uso de Bortezomibe (PS-341) em cães da raça Golden Retriever afetados pela Distrofia Muscular Progressiva (GRMD) - Avaliação da viabilidade da terapia e reestruturação da Distrofina Muscular.

Degree: PhD, Anatomia dos Animais Domésticos e Silvestres, 2009, University of São Paulo

A distrofia muscular progressiva no cão Golden Retriever (GRMD) é uma miopatia genética homóloga à Distrofia Muscular de Duchenne (DMD) que acomete humanos. A utilização… (more)

Subjects/Keywords: Bortezomib; Bortezomibe; Distrofina; Dystrophin; GRMD; GRMD model; Proteasome; Proteassoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Araújo, K. P. C. (2009). Uso de Bortezomibe (PS-341) em cães da raça Golden Retriever afetados pela Distrofia Muscular Progressiva (GRMD) - Avaliação da viabilidade da terapia e reestruturação da Distrofina Muscular. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/10/10132/tde-04022011-081208/ ;

Chicago Manual of Style (16th Edition):

Araújo, Karla Patrícia Cardoso. “Uso de Bortezomibe (PS-341) em cães da raça Golden Retriever afetados pela Distrofia Muscular Progressiva (GRMD) - Avaliação da viabilidade da terapia e reestruturação da Distrofina Muscular.” 2009. Doctoral Dissertation, University of São Paulo. Accessed August 14, 2020. http://www.teses.usp.br/teses/disponiveis/10/10132/tde-04022011-081208/ ;.

MLA Handbook (7th Edition):

Araújo, Karla Patrícia Cardoso. “Uso de Bortezomibe (PS-341) em cães da raça Golden Retriever afetados pela Distrofia Muscular Progressiva (GRMD) - Avaliação da viabilidade da terapia e reestruturação da Distrofina Muscular.” 2009. Web. 14 Aug 2020.

Vancouver:

Araújo KPC. Uso de Bortezomibe (PS-341) em cães da raça Golden Retriever afetados pela Distrofia Muscular Progressiva (GRMD) - Avaliação da viabilidade da terapia e reestruturação da Distrofina Muscular. [Internet] [Doctoral dissertation]. University of São Paulo; 2009. [cited 2020 Aug 14]. Available from: http://www.teses.usp.br/teses/disponiveis/10/10132/tde-04022011-081208/ ;.

Council of Science Editors:

Araújo KPC. Uso de Bortezomibe (PS-341) em cães da raça Golden Retriever afetados pela Distrofia Muscular Progressiva (GRMD) - Avaliação da viabilidade da terapia e reestruturação da Distrofina Muscular. [Doctoral Dissertation]. University of São Paulo; 2009. Available from: http://www.teses.usp.br/teses/disponiveis/10/10132/tde-04022011-081208/ ;


University of Debrecen

8. Mbamali, Monsobundu Michael. Pharmacotherapy of multiple myeloma .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 Multiple Myeloma is an incurable but treatable disease which predominantly affects the elderly. It constitutes about 10 percent of hematologic malignancies and 1 percent of… (more)

Subjects/Keywords: Multiple Myeloma; Lenalidomide; Bortezomib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mbamali, M. M. (n.d.). Pharmacotherapy of multiple myeloma . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/233612

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mbamali, Monsobundu Michael. “Pharmacotherapy of multiple myeloma .” Thesis, University of Debrecen. Accessed August 14, 2020. http://hdl.handle.net/2437/233612.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mbamali, Monsobundu Michael. “Pharmacotherapy of multiple myeloma .” Web. 14 Aug 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Mbamali MM. Pharmacotherapy of multiple myeloma . [Internet] [Thesis]. University of Debrecen; [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2437/233612.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Mbamali MM. Pharmacotherapy of multiple myeloma . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/233612

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Michigan

9. Wolter, Keith Garret. Mechanisms of Melanoma Cell Survival and Maintenance: Targeting Apoptosis and Authophagy to Improve Disease Treatment.

Degree: PhD, Cellular & Molecular Biology, 2011, University of Michigan

 Metastatic melanoma has proven exceptionally difficult to treat, in part due to consistent defects in cell death pathways. Overexpression of anti-apoptosis proteins from the Bcl-2… (more)

Subjects/Keywords: Melanoma; Autophagy; Apoptosis; Gossypol; Bortezomib; Molecular, Cellular and Developmental Biology; Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wolter, K. G. (2011). Mechanisms of Melanoma Cell Survival and Maintenance: Targeting Apoptosis and Authophagy to Improve Disease Treatment. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/84630

Chicago Manual of Style (16th Edition):

Wolter, Keith Garret. “Mechanisms of Melanoma Cell Survival and Maintenance: Targeting Apoptosis and Authophagy to Improve Disease Treatment.” 2011. Doctoral Dissertation, University of Michigan. Accessed August 14, 2020. http://hdl.handle.net/2027.42/84630.

MLA Handbook (7th Edition):

Wolter, Keith Garret. “Mechanisms of Melanoma Cell Survival and Maintenance: Targeting Apoptosis and Authophagy to Improve Disease Treatment.” 2011. Web. 14 Aug 2020.

Vancouver:

Wolter KG. Mechanisms of Melanoma Cell Survival and Maintenance: Targeting Apoptosis and Authophagy to Improve Disease Treatment. [Internet] [Doctoral dissertation]. University of Michigan; 2011. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2027.42/84630.

Council of Science Editors:

Wolter KG. Mechanisms of Melanoma Cell Survival and Maintenance: Targeting Apoptosis and Authophagy to Improve Disease Treatment. [Doctoral Dissertation]. University of Michigan; 2011. Available from: http://hdl.handle.net/2027.42/84630


University of Sydney

10. Al-Eisawi, Zaynab. Combinations between platinum drugs and bortezomib and changes in nature of administration in ovarian tumour models .

Degree: 2013, University of Sydney

 Currently, chemotherapy based on cisplatin and carboplatin is the primary treatment for ovarian cancer. Although cisplatin is carried into the cell by CTR1, the drug… (more)

Subjects/Keywords: Keywords: cisplatin; bortezomib; CTR1; resistance; combination; ovarian cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Al-Eisawi, Z. (2013). Combinations between platinum drugs and bortezomib and changes in nature of administration in ovarian tumour models . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/9465

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Al-Eisawi, Zaynab. “Combinations between platinum drugs and bortezomib and changes in nature of administration in ovarian tumour models .” 2013. Thesis, University of Sydney. Accessed August 14, 2020. http://hdl.handle.net/2123/9465.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Al-Eisawi, Zaynab. “Combinations between platinum drugs and bortezomib and changes in nature of administration in ovarian tumour models .” 2013. Web. 14 Aug 2020.

Vancouver:

Al-Eisawi Z. Combinations between platinum drugs and bortezomib and changes in nature of administration in ovarian tumour models . [Internet] [Thesis]. University of Sydney; 2013. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2123/9465.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Al-Eisawi Z. Combinations between platinum drugs and bortezomib and changes in nature of administration in ovarian tumour models . [Thesis]. University of Sydney; 2013. Available from: http://hdl.handle.net/2123/9465

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. GRACE NGAN JIE YIN. IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR.

Degree: 2017, National University of Singapore

Subjects/Keywords: Bortezomib; Mycobacterium; Caseinolytic Protease; Inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

YIN, G. N. J. (2017). IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/144391

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

YIN, GRACE NGAN JIE. “IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR.” 2017. Thesis, National University of Singapore. Accessed August 14, 2020. http://scholarbank.nus.edu.sg/handle/10635/144391.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

YIN, GRACE NGAN JIE. “IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR.” 2017. Web. 14 Aug 2020.

Vancouver:

YIN GNJ. IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR. [Internet] [Thesis]. National University of Singapore; 2017. [cited 2020 Aug 14]. Available from: http://scholarbank.nus.edu.sg/handle/10635/144391.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

YIN GNJ. IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR. [Thesis]. National University of Singapore; 2017. Available from: http://scholarbank.nus.edu.sg/handle/10635/144391

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


George Mason University

12. Arias Cardenas, Kelly. A Study of the Humanized Monoclonal Antibody CT109 in Combination with FOLFIRI and Bortezomib as a Treatment for Colorectal Cancer .

Degree: George Mason University

 Colorectal cancer ranks as the 2nd leading cause of cancer death in the United States. New drugs are urgently needed to increase the survival of… (more)

Subjects/Keywords: FOLFIRI; colorectal; cancer; Bortezomib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arias Cardenas, K. (n.d.). A Study of the Humanized Monoclonal Antibody CT109 in Combination with FOLFIRI and Bortezomib as a Treatment for Colorectal Cancer . (Thesis). George Mason University. Retrieved from http://hdl.handle.net/1920/11788

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Arias Cardenas, Kelly. “A Study of the Humanized Monoclonal Antibody CT109 in Combination with FOLFIRI and Bortezomib as a Treatment for Colorectal Cancer .” Thesis, George Mason University. Accessed August 14, 2020. http://hdl.handle.net/1920/11788.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Arias Cardenas, Kelly. “A Study of the Humanized Monoclonal Antibody CT109 in Combination with FOLFIRI and Bortezomib as a Treatment for Colorectal Cancer .” Web. 14 Aug 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Arias Cardenas K. A Study of the Humanized Monoclonal Antibody CT109 in Combination with FOLFIRI and Bortezomib as a Treatment for Colorectal Cancer . [Internet] [Thesis]. George Mason University; [cited 2020 Aug 14]. Available from: http://hdl.handle.net/1920/11788.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Arias Cardenas K. A Study of the Humanized Monoclonal Antibody CT109 in Combination with FOLFIRI and Bortezomib as a Treatment for Colorectal Cancer . [Thesis]. George Mason University; Available from: http://hdl.handle.net/1920/11788

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Southern California

13. Sainz, Marcos A. Design, synthesis, and biological evaluation of novel therapeutics for cancer.

Degree: PhD, Chemistry, 2015, University of Southern California

 This dissertation details my efforts towards the design, synthesis and biological evaluation of novel, small molecule anti-cancer agents. This was accomplished with a joint collaboration… (more)

Subjects/Keywords: organic chemistry; synthesis; medicinal chemistry; dUTPase; PNA; bortezomib; MEF2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sainz, M. A. (2015). Design, synthesis, and biological evaluation of novel therapeutics for cancer. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/518515/rec/1877

Chicago Manual of Style (16th Edition):

Sainz, Marcos A. “Design, synthesis, and biological evaluation of novel therapeutics for cancer.” 2015. Doctoral Dissertation, University of Southern California. Accessed August 14, 2020. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/518515/rec/1877.

MLA Handbook (7th Edition):

Sainz, Marcos A. “Design, synthesis, and biological evaluation of novel therapeutics for cancer.” 2015. Web. 14 Aug 2020.

Vancouver:

Sainz MA. Design, synthesis, and biological evaluation of novel therapeutics for cancer. [Internet] [Doctoral dissertation]. University of Southern California; 2015. [cited 2020 Aug 14]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/518515/rec/1877.

Council of Science Editors:

Sainz MA. Design, synthesis, and biological evaluation of novel therapeutics for cancer. [Doctoral Dissertation]. University of Southern California; 2015. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/518515/rec/1877

14. 이, 동민. Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death.

Degree: 2016, Ajou University

The ubiquitin-proteasome system is a complex and tightly controlled system in charge of degrading 80-90% of proteins, and is central to regulating cellular function and… (more)

Subjects/Keywords: bortezomib; nutlin-3; cancer; paraptosis; endoplasmic reticulum; mitochondria

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

이, . (2016). Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/13032 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022078

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

이, 동민. “Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death.” 2016. Thesis, Ajou University. Accessed August 14, 2020. http://repository.ajou.ac.kr/handle/201003/13032 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022078.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

이, 동민. “Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death.” 2016. Web. 14 Aug 2020.

Vancouver:

이 . Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death. [Internet] [Thesis]. Ajou University; 2016. [cited 2020 Aug 14]. Available from: http://repository.ajou.ac.kr/handle/201003/13032 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022078.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

이 . Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death. [Thesis]. Ajou University; 2016. Available from: http://repository.ajou.ac.kr/handle/201003/13032 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022078

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Kent State University

15. Shyam, Sunitha. S-phase Synchronization Promotes Chemoradiotherapy-induced Apoptosis in Prostate Cancer Cell Lines.

Degree: MS, College of Biomedical Sciences, 2007, Kent State University

 Prostate cancer is the second leading cause of death in men in the USA for the year 2007 and cells are generally resistant to treatments.… (more)

Subjects/Keywords: Biology, Molecular; Apo2L/TRAIL; Bortezomib; C4-2; PARP-1; aphidicolin; Cell; C4-2 cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shyam, S. (2007). S-phase Synchronization Promotes Chemoradiotherapy-induced Apoptosis in Prostate Cancer Cell Lines. (Masters Thesis). Kent State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=kent1185835523

Chicago Manual of Style (16th Edition):

Shyam, Sunitha. “S-phase Synchronization Promotes Chemoradiotherapy-induced Apoptosis in Prostate Cancer Cell Lines.” 2007. Masters Thesis, Kent State University. Accessed August 14, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=kent1185835523.

MLA Handbook (7th Edition):

Shyam, Sunitha. “S-phase Synchronization Promotes Chemoradiotherapy-induced Apoptosis in Prostate Cancer Cell Lines.” 2007. Web. 14 Aug 2020.

Vancouver:

Shyam S. S-phase Synchronization Promotes Chemoradiotherapy-induced Apoptosis in Prostate Cancer Cell Lines. [Internet] [Masters thesis]. Kent State University; 2007. [cited 2020 Aug 14]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=kent1185835523.

Council of Science Editors:

Shyam S. S-phase Synchronization Promotes Chemoradiotherapy-induced Apoptosis in Prostate Cancer Cell Lines. [Masters Thesis]. Kent State University; 2007. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=kent1185835523

16. Liapis, Konstantinos. Η μελέτη των μεταβολών που επάγονται απο τους νεότερους φαρμακευτικούς παράγοντες στα πλασματοκύτταρα και στο μικροπεριβάλλον των ασθενών με πολλαπλούν μυέλωμα και η συσχέτιση τους με κλινικά δεδομένα.

Degree: 2016, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Purpose: Maximizing the response rate to first-line therapy in multiple myeloma (MM) is important because it leads to improved outcome. Gene-expression studies have identified prognostic… (more)

Subjects/Keywords: Βορτεζομίμπη; Πολλαπλούν μυέλωμα; Γονιδιακή έκφραση; Φαρμακογενετική ανάλυση; Bortezomib; Multiple myeloma; Gene expression; Pharmacogenomics; Survivin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Liapis, K. (2016). Η μελέτη των μεταβολών που επάγονται απο τους νεότερους φαρμακευτικούς παράγοντες στα πλασματοκύτταρα και στο μικροπεριβάλλον των ασθενών με πολλαπλούν μυέλωμα και η συσχέτιση τους με κλινικά δεδομένα. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/37061

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Liapis, Konstantinos. “Η μελέτη των μεταβολών που επάγονται απο τους νεότερους φαρμακευτικούς παράγοντες στα πλασματοκύτταρα και στο μικροπεριβάλλον των ασθενών με πολλαπλούν μυέλωμα και η συσχέτιση τους με κλινικά δεδομένα.” 2016. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed August 14, 2020. http://hdl.handle.net/10442/hedi/37061.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Liapis, Konstantinos. “Η μελέτη των μεταβολών που επάγονται απο τους νεότερους φαρμακευτικούς παράγοντες στα πλασματοκύτταρα και στο μικροπεριβάλλον των ασθενών με πολλαπλούν μυέλωμα και η συσχέτιση τους με κλινικά δεδομένα.” 2016. Web. 14 Aug 2020.

Vancouver:

Liapis K. Η μελέτη των μεταβολών που επάγονται απο τους νεότερους φαρμακευτικούς παράγοντες στα πλασματοκύτταρα και στο μικροπεριβάλλον των ασθενών με πολλαπλούν μυέλωμα και η συσχέτιση τους με κλινικά δεδομένα. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2016. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10442/hedi/37061.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Liapis K. Η μελέτη των μεταβολών που επάγονται απο τους νεότερους φαρμακευτικούς παράγοντες στα πλασματοκύτταρα και στο μικροπεριβάλλον των ασθενών με πολλαπλούν μυέλωμα και η συσχέτιση τους με κλινικά δεδομένα. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2016. Available from: http://hdl.handle.net/10442/hedi/37061

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade de Lisboa

17. Esteves, Susana Luísa Augusto. Utilização de metodologia Bayesiana e métodos de comparação indirecta em meta-análise: uma aplicação ao tratamento de mieloma múltiplo.

Degree: 2009, Universidade de Lisboa

Tese de mestrado, Bioestatística, Universidade de Lisboa, Faculdade de Ciências, 2009

Nos últimos anos, os fármacos talidomida, bortezomib e lenalidomida vieram alterar o paradigma do… (more)

Subjects/Keywords: Meta-análise; Comparação indirecta; Mieloma múltiplo; Talidomida; Bortezomib; Lenalidomida; Teses de mestrado - 2009

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Esteves, S. L. A. (2009). Utilização de metodologia Bayesiana e métodos de comparação indirecta em meta-análise: uma aplicação ao tratamento de mieloma múltiplo. (Thesis). Universidade de Lisboa. Retrieved from http://www.rcaap.pt/detail.jsp?id=oai:repositorio.ul.pt:10451/4920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Esteves, Susana Luísa Augusto. “Utilização de metodologia Bayesiana e métodos de comparação indirecta em meta-análise: uma aplicação ao tratamento de mieloma múltiplo.” 2009. Thesis, Universidade de Lisboa. Accessed August 14, 2020. http://www.rcaap.pt/detail.jsp?id=oai:repositorio.ul.pt:10451/4920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Esteves, Susana Luísa Augusto. “Utilização de metodologia Bayesiana e métodos de comparação indirecta em meta-análise: uma aplicação ao tratamento de mieloma múltiplo.” 2009. Web. 14 Aug 2020.

Vancouver:

Esteves SLA. Utilização de metodologia Bayesiana e métodos de comparação indirecta em meta-análise: uma aplicação ao tratamento de mieloma múltiplo. [Internet] [Thesis]. Universidade de Lisboa; 2009. [cited 2020 Aug 14]. Available from: http://www.rcaap.pt/detail.jsp?id=oai:repositorio.ul.pt:10451/4920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Esteves SLA. Utilização de metodologia Bayesiana e métodos de comparação indirecta em meta-análise: uma aplicação ao tratamento de mieloma múltiplo. [Thesis]. Universidade de Lisboa; 2009. Available from: http://www.rcaap.pt/detail.jsp?id=oai:repositorio.ul.pt:10451/4920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Zarouli, Chrysothea. Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας.

Degree: 2013, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Paraprotein related peripheral neuropathy (PN) is frequently associated with treatment administration. Vincristine, thalidomide and more recently bortezomib are common neurotoxic agents inducing PN. The purpose… (more)

Subjects/Keywords: Νευροτοξική περιφερική νευροπάθεια; Πολλαπλούν μυέλωμα; Bortezomib; Drug induced peripheral neuropathy; Multiple myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zarouli, C. (2013). Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/40455

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zarouli, Chrysothea. “Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας.” 2013. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed August 14, 2020. http://hdl.handle.net/10442/hedi/40455.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zarouli, Chrysothea. “Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας.” 2013. Web. 14 Aug 2020.

Vancouver:

Zarouli C. Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2013. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10442/hedi/40455.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zarouli C. Μελέτη των νευρολογικών εκδηλώσεων σε ασθενείς με πλασματοκυτταρικές δυσκρασίες ως αποτέλεσμα εκδήλωσης της βασικής νόσου ή νευροτοξικής θεραπείας. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2013. Available from: http://hdl.handle.net/10442/hedi/40455

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

19. Manton, Christa A. Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma.

Degree: PhD, 2015, Texas Medical Center

  New therapeutic options are needed for glioblastoma, a deadly disease with a median survival of only 14 months with current treatment. The proteasome inhibitor… (more)

Subjects/Keywords: bortezomib; marizomib; proteasome; proteasome inhibitor; glioblastoma; caspase; apoptosis; vorinostat; histone deacetylase inhibitor; Cancer Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Manton, C. A. (2015). Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/545

Chicago Manual of Style (16th Edition):

Manton, Christa A. “Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma.” 2015. Doctoral Dissertation, Texas Medical Center. Accessed August 14, 2020. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/545.

MLA Handbook (7th Edition):

Manton, Christa A. “Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma.” 2015. Web. 14 Aug 2020.

Vancouver:

Manton CA. Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma. [Internet] [Doctoral dissertation]. Texas Medical Center; 2015. [cited 2020 Aug 14]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/545.

Council of Science Editors:

Manton CA. Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma. [Doctoral Dissertation]. Texas Medical Center; 2015. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/545


Freie Universität Berlin

20. Dabrowski, Robert. Untersuchungen zur Proliferation und Apoptose an normalen hämatopoetischen Progenitorzellen und an Zellen aus Linien hämatopoetischer Malignome unter dem Einfluss von Perifosin und in Kombination mit neuen Tumortherapeutika.

Degree: 2020, Freie Universität Berlin

 Introduction: Perifosine is an alkylphospholipid that inhibits the in many tumors activated PI3K/Akt/mTOR signaling pathway. Perifosine has been subject to clinical studies investigating its efficacy… (more)

Subjects/Keywords: perifosine; bortezomib; lenalidomide; hematopoietic; cytotoxicity; in vitro; progenitor cells; cell lines; ddc:610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dabrowski, R. (2020). Untersuchungen zur Proliferation und Apoptose an normalen hämatopoetischen Progenitorzellen und an Zellen aus Linien hämatopoetischer Malignome unter dem Einfluss von Perifosin und in Kombination mit neuen Tumortherapeutika. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-27014

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dabrowski, Robert. “Untersuchungen zur Proliferation und Apoptose an normalen hämatopoetischen Progenitorzellen und an Zellen aus Linien hämatopoetischer Malignome unter dem Einfluss von Perifosin und in Kombination mit neuen Tumortherapeutika.” 2020. Thesis, Freie Universität Berlin. Accessed August 14, 2020. http://dx.doi.org/10.17169/refubium-27014.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dabrowski, Robert. “Untersuchungen zur Proliferation und Apoptose an normalen hämatopoetischen Progenitorzellen und an Zellen aus Linien hämatopoetischer Malignome unter dem Einfluss von Perifosin und in Kombination mit neuen Tumortherapeutika.” 2020. Web. 14 Aug 2020.

Vancouver:

Dabrowski R. Untersuchungen zur Proliferation und Apoptose an normalen hämatopoetischen Progenitorzellen und an Zellen aus Linien hämatopoetischer Malignome unter dem Einfluss von Perifosin und in Kombination mit neuen Tumortherapeutika. [Internet] [Thesis]. Freie Universität Berlin; 2020. [cited 2020 Aug 14]. Available from: http://dx.doi.org/10.17169/refubium-27014.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dabrowski R. Untersuchungen zur Proliferation und Apoptose an normalen hämatopoetischen Progenitorzellen und an Zellen aus Linien hämatopoetischer Malignome unter dem Einfluss von Perifosin und in Kombination mit neuen Tumortherapeutika. [Thesis]. Freie Universität Berlin; 2020. Available from: http://dx.doi.org/10.17169/refubium-27014

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Melbourne

21. WANG, YAN. Computational modelling of multiple myeloma - bone interactions.

Degree: 2011, University of Melbourne

 Multiple Myeloma (MM) - Bone interactions are critical to systematic understanding and the management of MM-induced bone disease; however, the dynamics of the interplays of… (more)

Subjects/Keywords: multiple myeloma; bone; computational modeling; denosumab; pamidronate; bortezomib; biomedical engineering; computational biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

WANG, Y. (2011). Computational modelling of multiple myeloma - bone interactions. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/36077

Chicago Manual of Style (16th Edition):

WANG, YAN. “Computational modelling of multiple myeloma - bone interactions.” 2011. Doctoral Dissertation, University of Melbourne. Accessed August 14, 2020. http://hdl.handle.net/11343/36077.

MLA Handbook (7th Edition):

WANG, YAN. “Computational modelling of multiple myeloma - bone interactions.” 2011. Web. 14 Aug 2020.

Vancouver:

WANG Y. Computational modelling of multiple myeloma - bone interactions. [Internet] [Doctoral dissertation]. University of Melbourne; 2011. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/11343/36077.

Council of Science Editors:

WANG Y. Computational modelling of multiple myeloma - bone interactions. [Doctoral Dissertation]. University of Melbourne; 2011. Available from: http://hdl.handle.net/11343/36077


University of Adelaide

22. Turner, Dion Joel Lammas. Probing a Promiscuous Binding Pocket of the Proteasome.

Degree: 2019, University of Adelaide

 The proteasome is a multi-catalytic protease complex responsible for the degradation of unneeded, damaged or misfolded proteins. The proteasome is a validated target for the… (more)

Subjects/Keywords: Proteasome; Inhibitor; Boronate; Bortezomib; Azobenzene multiple myeloma; chymotrypsin; drug development; medicinal chemistry; organic chemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Turner, D. J. L. (2019). Probing a Promiscuous Binding Pocket of the Proteasome. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/124108

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Turner, Dion Joel Lammas. “Probing a Promiscuous Binding Pocket of the Proteasome.” 2019. Thesis, University of Adelaide. Accessed August 14, 2020. http://hdl.handle.net/2440/124108.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Turner, Dion Joel Lammas. “Probing a Promiscuous Binding Pocket of the Proteasome.” 2019. Web. 14 Aug 2020.

Vancouver:

Turner DJL. Probing a Promiscuous Binding Pocket of the Proteasome. [Internet] [Thesis]. University of Adelaide; 2019. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2440/124108.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Turner DJL. Probing a Promiscuous Binding Pocket of the Proteasome. [Thesis]. University of Adelaide; 2019. Available from: http://hdl.handle.net/2440/124108

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. 김, 인영. Mechanistic study on the therapeutic strategy to enhance glioma cell death through inhibition of proteasome and lysosome.

Degree: 2016, Ajou University

 Malignant gliomas, the most common brain tumors with high mortality, remain largely incurable despite multimodal treatments including surgical resection, radiotherapy, and chemotherapy. Thus, the researchers… (more)

Subjects/Keywords: proteostasis; protein degradation; bortezomib (BZ); chloroquine (CQ); eIF2a; endoplasmic reticulum (ER) vacuolation; lysosomal rupture

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

김, . (2016). Mechanistic study on the therapeutic strategy to enhance glioma cell death through inhibition of proteasome and lysosome. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/13045 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000023335

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

김, 인영. “Mechanistic study on the therapeutic strategy to enhance glioma cell death through inhibition of proteasome and lysosome.” 2016. Thesis, Ajou University. Accessed August 14, 2020. http://repository.ajou.ac.kr/handle/201003/13045 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000023335.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

김, 인영. “Mechanistic study on the therapeutic strategy to enhance glioma cell death through inhibition of proteasome and lysosome.” 2016. Web. 14 Aug 2020.

Vancouver:

김 . Mechanistic study on the therapeutic strategy to enhance glioma cell death through inhibition of proteasome and lysosome. [Internet] [Thesis]. Ajou University; 2016. [cited 2020 Aug 14]. Available from: http://repository.ajou.ac.kr/handle/201003/13045 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000023335.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

김 . Mechanistic study on the therapeutic strategy to enhance glioma cell death through inhibition of proteasome and lysosome. [Thesis]. Ajou University; 2016. Available from: http://repository.ajou.ac.kr/handle/201003/13045 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000023335

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

24. 이, 아름. Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death.

Degree: 2019, Ajou University

Bortezomib (Btz), a proteasome inhibitor (PI), is effective in treating multiple myeloma and mantle cell lymphoma, but its anticancer effects are not satisfactory in solid… (more)

Subjects/Keywords: Bortezomib; Lercanidipine; ER stress; Mitochondrial Ca2+ overload; Paraptosis; 프로테아좀 억제제; 미토콘드리아 칼슘이온; misfolded 단백질

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

이, . (2019). Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/17887 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000029322

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

이, 아름. “Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death.” 2019. Thesis, Ajou University. Accessed August 14, 2020. http://repository.ajou.ac.kr/handle/201003/17887 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000029322.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

이, 아름. “Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death.” 2019. Web. 14 Aug 2020.

Vancouver:

이 . Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death. [Internet] [Thesis]. Ajou University; 2019. [cited 2020 Aug 14]. Available from: http://repository.ajou.ac.kr/handle/201003/17887 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000029322.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

이 . Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death. [Thesis]. Ajou University; 2019. Available from: http://repository.ajou.ac.kr/handle/201003/17887 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000029322

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

25. Αναργύρου, Κωνσταντίνος. Μελέτη της προγνωστικής αξίας της αγγειογένεσης του μυελού των οστών σε ασθενείς με πολλαπλούν μυέλωμα.

Degree: 2008, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Multiple myeloma (MM) is a B-cell lymphoproliferative disease with a median survival of approximately 3 years. Intensive research of the last decade has enlightened the… (more)

Subjects/Keywords: Πολλαπλούν μυέλωμα; Πρόγνωση; Αγγειογένεση; Μπορτεζομίμπη; Λόγος αγειοποιητίνη-1 / αγγειοποιητίνη-2; Multiple myeloma; Prognosis; Angiogenesis; Bortezomib; Angiopoietin-1 / angiopoietin-2 ratio

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Αναργύρου, . . (2008). Μελέτη της προγνωστικής αξίας της αγγειογένεσης του μυελού των οστών σε ασθενείς με πολλαπλούν μυέλωμα. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/23894

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Αναργύρου, Κωνσταντίνος. “Μελέτη της προγνωστικής αξίας της αγγειογένεσης του μυελού των οστών σε ασθενείς με πολλαπλούν μυέλωμα.” 2008. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed August 14, 2020. http://hdl.handle.net/10442/hedi/23894.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Αναργύρου, Κωνσταντίνος. “Μελέτη της προγνωστικής αξίας της αγγειογένεσης του μυελού των οστών σε ασθενείς με πολλαπλούν μυέλωμα.” 2008. Web. 14 Aug 2020.

Vancouver:

Αναργύρου . Μελέτη της προγνωστικής αξίας της αγγειογένεσης του μυελού των οστών σε ασθενείς με πολλαπλούν μυέλωμα. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2008. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10442/hedi/23894.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Αναργύρου . Μελέτη της προγνωστικής αξίας της αγγειογένεσης του μυελού των οστών σε ασθενείς με πολλαπλούν μυέλωμα. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2008. Available from: http://hdl.handle.net/10442/hedi/23894

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

26. Μπεφάνη, Χριστίνα. Διερεύνηση του ρόλου του HIF-2α στην κυτταρική ομοιοστασία.

Degree: 2013, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας

Τhe hypoxia inducible transcription factors, HIF-1α and HIF-2α, play central roles in the cellular response to hypoxia. In the present thesis, the molecular mechanisms of… (more)

Subjects/Keywords: Υποξία; Ηπατοκαρκίνωμα; Ερυθροποιητίνη; Κοβάλτιο; Κινάση της καζεΐνης; Βορτεζομίδη; Hypoxia; HIF-2α; Hepatocellular carcinoma; Erythropoetin; Cobalt; Casein kinase; ERK1/2; Bortezomib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Μπεφάνη, . . (2013). Διερεύνηση του ρόλου του HIF-2α στην κυτταρική ομοιοστασία. (Thesis). University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Retrieved from http://hdl.handle.net/10442/hedi/33294

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Μπεφάνη, Χριστίνα. “Διερεύνηση του ρόλου του HIF-2α στην κυτταρική ομοιοστασία.” 2013. Thesis, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Accessed August 14, 2020. http://hdl.handle.net/10442/hedi/33294.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Μπεφάνη, Χριστίνα. “Διερεύνηση του ρόλου του HIF-2α στην κυτταρική ομοιοστασία.” 2013. Web. 14 Aug 2020.

Vancouver:

Μπεφάνη . Διερεύνηση του ρόλου του HIF-2α στην κυτταρική ομοιοστασία. [Internet] [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2013. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10442/hedi/33294.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Μπεφάνη . Διερεύνηση του ρόλου του HIF-2α στην κυτταρική ομοιοστασία. [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2013. Available from: http://hdl.handle.net/10442/hedi/33294

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. Βουτσαδάκης, Ιωάννης. Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές.

Degree: 2008, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας

Background: Cyclooxygenase-2 (Cox-2) is an important enzyme in colorectal carcinogenesis and Cox inhibitors such as aspirin (acetylsalicylic acid, ASA) have shown both Cox-2 dependent and… (more)

Subjects/Keywords: Καρκίνος, κολο-ορθικός; Κυκλοοξυγενάση; Πρωτεάσωμα; Ασπιρίνη; Μπορτεζομίμπη; Κυτταρικές σειρές; Colorectal cancer; Cyclooxygenase-2; Proteasome; Aspirin; Bortezomib; Cell lines; HT-29; HCT116

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Βουτσαδάκης, . . (2008). Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές. (Thesis). University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Retrieved from http://hdl.handle.net/10442/hedi/17179

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Βουτσαδάκης, Ιωάννης. “Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές.” 2008. Thesis, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Accessed August 14, 2020. http://hdl.handle.net/10442/hedi/17179.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Βουτσαδάκης, Ιωάννης. “Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές.” 2008. Web. 14 Aug 2020.

Vancouver:

Βουτσαδάκης . Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές. [Internet] [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2008. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/10442/hedi/17179.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Βουτσαδάκης . Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές. [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2008. Available from: http://hdl.handle.net/10442/hedi/17179

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

28. M. CHIRIVA INTERNATI. PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA.

Degree: 2012, Università degli Studi di Milano

 The American Cancer Society expects that there will be more than 20,000 new cases of multiple myeloma (MM) in the US in 2011 and despite… (more)

Subjects/Keywords: multiple myeloma; cancer; B cells; galectin-3C; bortezomib; animal model; nod/scid; Settore BIO/16 - Anatomia Umana

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

INTERNATI, M. C. (2012). PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/168390

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

INTERNATI, M. CHIRIVA. “PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA.” 2012. Thesis, Università degli Studi di Milano. Accessed August 14, 2020. http://hdl.handle.net/2434/168390.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

INTERNATI, M. CHIRIVA. “PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA.” 2012. Web. 14 Aug 2020.

Vancouver:

INTERNATI MC. PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA. [Internet] [Thesis]. Università degli Studi di Milano; 2012. [cited 2020 Aug 14]. Available from: http://hdl.handle.net/2434/168390.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

INTERNATI MC. PRECLINICAL TESTING OF GALECTIN-3C FOR MULTIPLE MYELOMA. [Thesis]. Università degli Studi di Milano; 2012. Available from: http://hdl.handle.net/2434/168390

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

29. Kosturakis, Alyssa K. MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION.

Degree: MS, 2014, Texas Medical Center

  MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION Alyssa Katarina Kosturakis, BA Supervisory Professor: Patrick M. Dougherty, PhD Peripheral neuropathy… (more)

Subjects/Keywords: multiple myeloma; bortezomib; chemotherapy-induced peripheral neuropathy; quantitative sensory testing; Meissner's corpuscle; minocycline; Medical Neurobiology; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kosturakis, A. K. (2014). MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION. (Thesis). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/475

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kosturakis, Alyssa K. “MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION.” 2014. Thesis, Texas Medical Center. Accessed August 14, 2020. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/475.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kosturakis, Alyssa K. “MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION.” 2014. Web. 14 Aug 2020.

Vancouver:

Kosturakis AK. MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION. [Internet] [Thesis]. Texas Medical Center; 2014. [cited 2020 Aug 14]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/475.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kosturakis AK. MULTIPLE MYELOMA AND ITS TREATMENT ALTER PERIPHERAL NERVOUS SYSTEM STRUCTURE AND FUNCTION. [Thesis]. Texas Medical Center; 2014. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/475

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

30. Robinson, Caleb R. Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy.

Degree: PhD, 2014, Texas Medical Center

Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma and other non-solid malignancies, alone or in combination with other chemotherapy drugs.… (more)

Subjects/Keywords: bortezomib; astrocyte; CIPN; chemotherapy-induced peripheral neuropathy; Medicine and Health Sciences; Nervous System Diseases; Neuroscience and Neurobiology; Other Neuroscience and Neurobiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Robinson, C. R. (2014). Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/485

Chicago Manual of Style (16th Edition):

Robinson, Caleb R. “Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy.” 2014. Doctoral Dissertation, Texas Medical Center. Accessed August 14, 2020. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/485.

MLA Handbook (7th Edition):

Robinson, Caleb R. “Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy.” 2014. Web. 14 Aug 2020.

Vancouver:

Robinson CR. Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy. [Internet] [Doctoral dissertation]. Texas Medical Center; 2014. [cited 2020 Aug 14]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/485.

Council of Science Editors:

Robinson CR. Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy. [Doctoral Dissertation]. Texas Medical Center; 2014. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/485

[1] [2] [3]

.